Luo Nancy, Rogers Joseph G, Dodson Gwen C, Patel Chetan B, Galanos Anthony N, Milano Carmelo A, O'Connor Christopher M, Mentz Robert J
Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina.
Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina.
Am J Cardiol. 2016 Sep 1;118(5):733-8. doi: 10.1016/j.amjcard.2016.06.010. Epub 2016 Jun 21.
Within the last decade, advancements in left ventricular assist device therapy have allowed patients with end-stage heart failure (HF) to live longer and with better quality of life. Like other life-saving interventions, however, there remains the risk of complications including infections, bleeding episodes, and stroke. The candidate for left ventricular assist device therapy faces complex challenges going forward, both physical and psychological, many of which may benefit from the application of palliative care principles by trained specialists. Despite these advantages, palliative care remains underused in many advanced HF programs. Here, we describe the benefits of palliative care, barriers to use within HF, and specific applications to the integrated care of patients on mechanical circulatory support.
在过去十年中，左心室辅助装置治疗取得了进展，使终末期心力衰竭（HF）患者能够活得更长，生活质量更高。然而，与其他挽救生命的干预措施一样，仍然存在并发症风险，包括感染、出血事件和中风。左心室辅助装置治疗的候选人在未来面临着复杂的身体和心理挑战，其中许多挑战可能受益于受过培训的专家应用姑息治疗原则。尽管有这些优势，但姑息治疗在许多晚期心力衰竭项目中仍未得到充分利用。在此，我们描述了姑息治疗的益处、心力衰竭治疗中使用姑息治疗的障碍，以及在机械循环支持患者综合护理中的具体应用。
